ProQR Therapeutics (PRQR) Non-Current Assets (2021 - 2025)

ProQR Therapeutics (PRQR) has disclosed Non-Current Assets for 5 consecutive years, with $14.7 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 2.51% to $14.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.7 million through Dec 2025, down 2.51% year-over-year, with the annual reading at $14.7 million for FY2025, 2.51% down from the prior year.
  • Non-Current Assets hit $14.7 million in Q4 2025 for ProQR Therapeutics, down from $15.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $20.7 million in Q4 2021 to a low of $14.7 million in Q4 2025.
  • Historically, Non-Current Assets has averaged $17.2 million across 5 years, with a median of $17.2 million in 2022.
  • Biggest five-year swings in Non-Current Assets: grew 5.68% in 2023 and later fell 17.05% in 2024.
  • Year by year, Non-Current Assets stood at $20.7 million in 2021, then dropped by 16.9% to $17.2 million in 2022, then rose by 5.68% to $18.2 million in 2023, then fell by 17.05% to $15.1 million in 2024, then decreased by 2.51% to $14.7 million in 2025.
  • Business Quant data shows Non-Current Assets for PRQR at $14.7 million in Q4 2025, $15.1 million in Q4 2024, and $18.2 million in Q4 2023.